Show simple item record

dc.contributor.authorMatur, Zeliha
dc.contributor.authorParman, Yesim Gulsen
dc.date.accessioned2021-03-03T14:45:04Z
dc.date.available2021-03-03T14:45:04Z
dc.identifier.citationMatur Z., Parman Y. G. , "Use of Botulinum Toxin Type a in the Treatment of Spasticity", NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, cilt.47, ss.40-43, 2010
dc.identifier.issn1300-0667
dc.identifier.othervv_1032021
dc.identifier.otherav_3b3a662d-8408-4553-8024-2ebac16b9060
dc.identifier.urihttp://hdl.handle.net/20.500.12627/43784
dc.identifier.urihttps://doi.org/10.4274/npa.y5929
dc.description.abstractSpasticity is a component of the upper motor neuron syndrome and occurs after maladaptive improvement. Velocity-dependent increase in muscle tonus causes restricted movement, muscle shortness, pain, joint malpositions and contractures. When spasticity is harmful, it has to be treated. The treatment of spasticity requires a multidisciplinary approach. Botulinum toxin type A is effective when used with other treatment modalities, especially with physiotherapy. (Archives of Neuropsychiatry 2010; 47 Supplement: 40-3)
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectNöroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleUse of Botulinum Toxin Type a in the Treatment of Spasticity
dc.typeMakale
dc.relation.journalNOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume47
dc.identifier.startpage40
dc.identifier.endpage43
dc.contributor.firstauthorID194377


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record